Skip to search formSkip to main contentSkip to account menu

MK-626

National Institutes of Health

Related topics

Related topics

2 relations
analogs & derivatives

Broader (1)

sitagliptin phosphate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Dipeptidyl peptidase-4 inhibitor prevents the progression of heart failure after myocardial infarction in mice
Background: Dipeptidyl peptidase-4 (DPP-4) inhibitors are newly available drugs for diabetes mellitus, but it is unclear whether… 
2012
2012
MK-626, a dipeptidyl peptidase-4 inhibitor, does not improve the hyperglycemia or hyperinsulinemia of nonobese diabetic MKR mice.
Dipeptidyl peptidase-4 (DPP-4) inhibitors increase circulating levels of incretin hormones, which can enhance insulin secretion… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)